MW

Michael Wagner

SA Sanofi: 11 patents #1 of 232Top 1%
Overall (2017): #5,723 of 506,227Top 2%
11
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9834527 Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals Andreas Evers, Christopher Kallus, Hermut Wehlan 2017-12-05
9789165 Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists Dieter Kadereit, Katrin Lorenz, Andreas Evers, Torsten Haack, Bernd Henkel +2 more 2017-10-17
9775904 Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists Martin Bossart, Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin 2017-10-03
9771406 Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 Martin Bossart, Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin +1 more 2017-09-26
9758561 Dual GLP-1/glucagon receptor agonists derived from exendin-4 Martin Bossart, Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin +1 more 2017-09-12
9751926 Dual GLP-1/GIP receptor agonists Dieter Kadereit, Katrin Lorenz, Andreas Evers, Torsten Haack, Bernd Henkel +2 more 2017-09-05
9750788 Non-acylated exendin-4 peptide analogues Dieter Kadereit, Katrin Lorenz, Andreas Evers, Torsten Haack, Bernd Henkel +2 more 2017-09-05
9745360 Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists Torsten Haack, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Lorenz +1 more 2017-08-29
9694053 Dual GLP-1/glucagon receptor agonists Torsten Haack, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Bossart +1 more 2017-07-04
9688645 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Christopher Kallus, Mark Broenstrup, Andreas Evers, Anja Globisch, Herman Schreuder 2017-06-27
9670261 Functionalized exendin-4 derivatives Torsten Haack, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Lorenz +1 more 2017-06-06